1-6 of 6
Catherine Thieblemont, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Are Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) Occurring during the Course of Lymphoma (Ly) Always Therapy Related?

Camille Bigenwald, Stephanie Harel, Florian Chevillon, Damien Roos-Weil, Olivier A. Bernard, PhD, Sandy Amorim, MD, Pauline Brice, MD, Ades Lionel, Anne Marie Nloga, Marie Sébert, MD, Thorsten Braun, MD PhD, Virginie Eclache, Catherine Thieblemont, MDPhD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2886.
https://doi.org/10.1182/blood.V126.23.2886.2886
Published: 2015
Journal Articles

A Phase Ib Study of Obinutuzumab Combined with Lenalidomide for Relapsed/Refractory Follicular B-Cell Lymphoma

Franck Morschhauser, MD PhD, Gilles Salles, MDPhD, Steven Le Gouill, Herve Tilly, MD PhD, Catherine Thieblemont, MDPhD, Krimo Bouabdallah, MD, Guillaume Cartron, MD, Roch Houot, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4458.
https://doi.org/10.1182/blood.V124.21.4458.4458
Published: 2014
Journal Articles

T 3 : A Multicenter Phase IB Dose Escalation Study to Evaluate the Safety, Feasibility and Efficacy of the Temsirolimus (Torisel™)-CHOP-Rituximab (T-R-CHOP), Temsirolimus (Torisel™)-FC-Rituximab (T-R-FC) and Temsirolimus (Torisel™)- DHA-Rituximab (T-R-DHA) for the Treatment of Patients with Relapsed/Refractory Mantle Cell Lymphoma (MCL), a Lysa Study

Steven Le Gouill, MD PhD, Krimo Bouabdallah, MD, Guillaume Cartron, MD, Remy Gressin, MD, Thierry Lamy, Bertrand Coiffier, MD PhD, Catherine Thieblemont, MDPhD, Corinne Haioun, MD PhD, Olivier Casasnovas, MD, Emmanuel Gyan, MD PhD, Olivier Hermine, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4426.
https://doi.org/10.1182/blood.V124.21.4426.4426
Published: 2014
Journal Articles

High Dose Therapy and Autologous Stem Cell Transplantation in Marginal Zone Lymphoma : An EBMT-FIL-Gimeto Retrospective Study

Irit Avivi, MD, Luca Arcaini, MD, Virginia Ferretti, MD, Ariane Boumendil, PhD, Herve Finel, Cristiana Pascutto, PhD, Giuseppe Milone, MD, Francesco Zaja, MD, Devizzi Liliana, MD, Maurizio Musso, MD, Blaise Didier, Gilles Salles, MDPhD, Mohammed Wattad, MD, Emmanuelle Nicolas-Virelizier, MD, Martin Gramatzki, MD, Jean-Henri Bourhis, MD PhD, Denis Caillot, MD, Shannon Haenel, DO, Anette Haenel, Gerhard Held, MD, Catherine Thieblemont, MDPhD, Pavel Jindra, MD PhD, David Pohlreich, François Guilhot, MD, Martin Bornhaeuser, Per T. Ljungman, MD PhD, Christof Scheid, Norbert Ifrah, MD, Christian Berthou, Peter Dreger, MD, Silvia Montoto, MD, Annarita Conconi, MD
Journal: Blood
Blood (2014) 124 (21): 2526.
https://doi.org/10.1182/blood.V124.21.2526.2526
Published: 2014
Journal Articles

Minimal Residual Disease Monitoring By 8-Color Flow Cytometry in Mantle Cell Lymphoma Is Complementary to Q-PCR Monitoring and Will Facilitate Pre-Emptive Treatment: An EU-MCL and Lysa Study

Morgane Cheminant, Stephanie Schmit, Aurore Touzart, MD, Coralie Derrieux, MD, Marie-Hélène Delfau-Larue, MD PhD, Catherine Thieblemont, MDPhD, Vincent Ribrag, MD, Loic Ysebaert, MDPhD, Fabrice Jardin, MD PhD, Stephane Cheze, MD, Francois Lefrère, MD, Richard Delarue, MD, Christiane Pott, MD PhD, Eva Hoster, PhD, Martin Dreyling, Vahid Asnafi, MDPhD, Olivier Hermine, MD PhD, Elizabeth Macintyre, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1657.
https://doi.org/10.1182/blood.V124.21.1657.1657
Published: 2014
Journal Articles

No Increased Risk of Secondary Neoplasms in Patients Treated with Rituximab for Non-Hodgkin’s Lymphoma : A Meta-Analysis of 9 Trials

Isabelle Fleury, MD, Sylvie Chevret, MD PhD, Michael Pfreundschuh, Gilles Salles, MDPhD, Bertrand Coiffier, MD PhD, Marinus H.J. van Oers, Christian Gisselbrecht, MDPhD, Emanuele Zucca, MD, Michael Herold, MDPhD, Michele Ghielmini, MD, Catherine Thieblemont, MDPhD
Journal: Blood
Blood (2014) 124 (21): 1659.
https://doi.org/10.1182/blood.V124.21.1659.1659
Published: 2014